FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients

The FDA has approved Lipfendra, a first-of-its-kind pill by Merck, to significantly reduce cholesterol in high-risk patients. This oral medication offers a cost-effective alternative to previously available expensive injectable treatments for lowering dangerous cholesterol levels.